Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Neuro-Oncology
Published in: Journal of Neuro-Oncology 3/2012

01-02-2012 | Clinical Study – Patient Study

Dosimetric comparison of Linac-based (BrainLAB®) and robotic radiosurgery (CyberKnife®) stereotactic system plans for acoustic schwannoma

Authors: Debnarayan Dutta, S. Balaji Subramanian, V. Murli, H. Sudahar, P. G. Gopalakrishna Kurup, Mahadev Potharaju

Published in: Journal of Neuro-Oncology | Issue 3/2012

Login to get access

Abstract

A dosimetric comparison of linear accelerator (LA)-based (BrainLAB) and robotic radiosurgery (RS) (CyberKnife) systems for acoustic schwannoma (Acoustic neuroma, AN) was carried out. Seven patients with radiologically confirmed unilateral AN were planned with both an LA-based (BrainLAB) and robotic RS (CyberKnife) system using the same computed tomography (CT) dataset and contours. Gross tumour volume (GTV) was contoured on post-contrast magnetic resonance imaging (MRI) scan [planning target volume (PTV) margin 2 mm]. Planning and calculation were done with appropriate calculation algorithms. The prescribed isodose in both systems was considered adequate to cover at least 95% of the contoured target. Plan evaluations were done by examining the target coverage by the prescribed isodose line, and high- and low-dose volumes. Isodose plans and dose volume histograms generated by the two systems were compared. There was no statistically significant difference between the contoured volumes between the systems. Tumour volumes ranged from 380 to 3,100 mm3. Dose prescription was 13–15 Gy in single fraction (median prescribed isodose 85%). There were no significant differences in conformity index (CI) (0.53 versus 0.58; P = 0.225), maximum brainstem dose (4.9 versus 4.7 Gy; P = 0.935), 2.5-Gy volume (39.9 versus 52.3 cc; P = 0.238) or 5-Gy volume (11.8 versus 16.8 cc; P = 0.129) between BrainLAB and CyberKnife system plans. There were statistically significant differences in organs at risk (OAR) doses, such as mean cochlear dose (6.9 versus 5.4 Gy; P = 0.001), mean mesial temporal dose (2.6 versus 1.7 Gy; P = 0.07) and high-dose (10 Gy) volume (3.2 versus 5.2 cc; P = 0.017). AN patients planned with the CyberKnife system had superior OAR (cochlea and mesial temporal lobe) sparing compared with those planned with the Linac-based system. Further evaluation of these findings in prospective studies with clinical correlation will provide actual clinical benefit from the dosimetric superiority of CyberKnife.
Literature
1.
Propp JM, McCarthy BJ, Davis FG, Preston-Martin S (2006) Descriptive epidemiology of vestibular schwannomas. Neuro Oncol 8:1–11PubMedCrossRef
2.
Leksell L (1971) A note on the treatment of acoustic tumors. Acta Chir Scand 137:763–765PubMed
3.
Myrseth E, Moller P, Pedersen PH, Lund-Johansen M (2009) Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study. 661-653 Neurosurgery 64:654–661
4.
Nikolopoulos TP, O’Donoghue GM (2002) Acoustic neuroma management: an evidence-based medicine approach. Otol Neurotol 23:534–541PubMedCrossRef
5.
Pollock BE, Driscoll CL, Foote RL, Link MJ, Gorman DA, Bauch CD, Mandrekar JN, Krecke KN, Johnson CH (2006) Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 59:77–85PubMedCrossRef
6.
Kaylie DM, Horgan MJ, Delashaw JB, McMenomey SO (2000) A meta-analysis comparing outcomes of microsurgery and gamma knife radiosurgery. Laryngoscope 110:1850–1856PubMedCrossRef
7.
Kondziolka D, Lunsford LD, McLaughlin MR (1998) Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 339:1426–1433PubMedCrossRef
8.
Abram S, Rosenblatt P, Holcomb S (2007) Stereotactic radiation techniques in the treatment of acoustic schwannomas. Otolaryngol Clin North Am 40:571–588PubMedCrossRef
9.
Hempel JM, Hempel E, Wowra B, Schichor Ch, Muacevic A, Riederer A (2006) Functional outcome after gamma knife treatment in vestibular schwannoma. Eur Arch Otorhinolaryngol 263(8):714–718PubMedCrossRef
10.
Tamura M, Murata N, Hayashi M, Roche PH, Régis J (2008) Facial nerve function insufficiency after radiosurgery versus microsurgery. Prog Neurol Surg 21:108–118PubMedCrossRef
11.
Régis J, Delsanti C, Roche PH, Thomassin JM, Pellet W (2004) Functional outcomes of radiosurgical treatment of vestibular schwannomas: 1000 successive cases and review of the literature. Neurochirurgie 50(2–3 Pt 2):301–311
12.
Karpinos M, Teh BS, Zeck O, Carpenter LS, Phan C, Mai WY, Lu HH, Chiu JK, Butler EB, Gormley WB, Woo SY (2002) Treatment of acoustic neuroma: stereotactic radiosurgery vs. microsurgery. Int J Radiat Oncol Biol Phys 54:1410–1421PubMedCrossRef
13.
Paek SH, Chung HT, Jeong SS, Park CK, Kim CY, Kim JE, Kim DG, Jung HW (2005) Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Cancer 104:580–590PubMedCrossRef
14.
Miller RC, Foote RL, Coffey RJ, Sargent DJ, Gorman DA, Schomberg PJ, Kline RW (1999) Decrease in cranial nerve complications after radiosurgery for acoustic neuromas: a prospective study of dose and volume. Int J Radiat Oncol Biol Phys 43:305–311PubMedCrossRef
15.
Yu C, Aho C, Liu C, Giannotta S (2006) Dosimetric comparison of gamma knife vs. cyberknife radiosurgery for patients with tumors near optic apparatus. Med Phys 33:2091
16.
Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol 24(8):1305–1309PubMedCrossRef
17.
Jalali R, Mullick I, Dutta D, Gupta T, Sarin R (2010) Age and radiotherapy doses to left temporal lobe predict neurocognitive outcomes in young patients with benign and low grade brain tumours: data from a prospective trial of stereotactic conformal radiation therapy. Int J Radiat Oncol Biol Phys 77(4):974–979PubMedCrossRef
18.
Tamura M, Carron R, Yomo S, Arkha Y, Muraciolle X, Porcheron D, Thomassin JM, Roche PH, Régis J (2009) Hearing preservation after gamma knife radiosurgery for vestibular schwannomas presenting with high-level hearing. Neurosurgery 64(2):289–296PubMedCrossRef
19.
Kano H, Kondziolka D, Khan A, Flickinger JC, Lunsford LD (2009) Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J Neurosurg 111(4):863–873PubMedCrossRef
20.
Chera BS, Amdur RJ, Robert J, Patel P, Mendenhall WM (2009) A radiation oncologist’s guide to contouring the hippocampus. Am J Clin Oncol 32(1):20–22PubMedCrossRef
21.
22.
Régis J, Bartolomei F, Rey M, Hayashi M, Chauvel P, Peragut JC (2000) Gamma knife surgery for mesial temporal lobe epilepsy. J Neurosurg 93 Suppl 3:141–146
23.
Rheims S, Fischer C, Ryvlin P, Isnard J, Guenot M, Tamura M, Regis J, Mauguiere F (2008) Long-term outcome of gamma-knife surgery in temporal lobe epilepsy. Epilepsy Res 80(1):23–29PubMedCrossRef
24.
Kapoor S, Batra S, Carson K, Shuck J, Kharkar S, Gandhi R,Jackson J, Wemmer J, Terezakis S, Shokek O, Kleinberg L, Rigamonti D (2010) Long-term outcomes of vestibular schwannomas treated with fractionated stereotactic radiotherapy: an institutional experience. Int J Radiat Oncol Biol Phys [PMID: 20884130]
25.
Lutz W, Winston KR, Maleki N (1988) A system for stereotactic radiosurgery with a linear accelerator. Int J Radiat Oncol Biol Phys 14:373–381PubMedCrossRef
26.
Kilby W, Dooley JR, Kuduvalli G, Sayeh S, Maurer Jr SCR (2010) The CyberKnife® Robotic Radiosurgery System in 2010. Technol Cancer Res Treat ISSN 9(5):1533–1546
27.
Munshi A (2009) Randomized study way out? Randomised controlled trials: on the way out? Clin Oncol (R Coll Radiol) 21(5):427–428CrossRef
Metadata
Title
Dosimetric comparison of Linac-based (BrainLAB®) and robotic radiosurgery (CyberKnife®) stereotactic system plans for acoustic schwannoma
Authors
Debnarayan Dutta
S. Balaji Subramanian
V. Murli
H. Sudahar
P. G. Gopalakrishna Kurup
Mahadev Potharaju
Publication date
01-02-2012
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2012
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-011-0703-5

Other articles of this Issue 3/2012

Journal of Neuro-Oncology 3/2012 Go to the issue

Laboratory Investigation - Human/Animal Tissue

Isolation of a new cell population in the glioblastoma microenvironment

Laboratory Investigation - Human/Animal Tissue

Downregulation of KIF23 suppresses glioma proliferation

Laboratory Investigation - Human/Animal Tissue

HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis

Topic Review

Is there a role for high dose chemotherapy with hematopoietic stem cell rescue in patients with relapsed supratentorial PNET?

Clinical Study – Patient Study

Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma

Clinical Study – Patient Study

Patterns of care and survival for glioblastoma patients in the Veterans population